Table 2.

The ratios of Th1/Th2 and Th17/Treg in controls and patients with UCC or CIN or HPV

	Th1/Th2	Th17/Treg
Control group (n=20)	10.38±7.80	0.52±0.13
HPV group (n=20)	11.17±8.13	0.63±0.17
CIN group (n=61)	3.50±1.51a,b	1.88±0.80a,b
UCC group (n=38)	1.43±0.71a,b,c	2.35±0.41a,b,c

Compared to the control group;

^a P<0.05.

Compared to the HPV group;

^b P<0.05.

Compared to the CIN group;

^c P<0.05.